NVCT
HealthcareNuvectis Pharma, Inc.
$8.31-0.40 (-4.54%)
Prev Close
$8.71
Open
$8.66
High
$8.70
Low
$8.24
Volume
52.4K
Market Cap
$240.5M
P/E
—
Div Yield
—
Over the past 12 months, insider activity at Nuvectis Pharma, Inc. (NVCT) has been exclusively buying, with 8 insider purchases totaling $1.85M and 0 insider sales totaling $0.00. The most recent insider transaction was by BENTSUR RON (Chairman & CEO), who purchased $28.6K worth of shares on Nov 5, 2025. Nuvectis Pharma, Inc. operates in the Healthcare sector, within the Biotechnology industry, with a market cap of $240.5M.
Buys (12M)
8
$1.85M
Sells (12M)
0
$0.00
Net Activity
Net Buyer
$1.85M
Active Insiders
4
last 12 mo
NVCT Price Chart
NVCT Insider Trading Activity
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025↗ | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $5.72 | $28.6K | 0 |
| Nov 5, 2025↗ | Kaplan Matthew L. | Director | Buy | 11,000 | $5.84 | $64.2K | 0 |
| Nov 5, 2025↗ | Sanchez Juan | Director | Buy | 13,000 | $5.79 | $75.3K | 0 |
| Oct 23, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 154,770 | $6.18 | $957.1K | 0 |
| Jun 20, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 5,603 | $7.99 | $44.8K | 0 |
| Jun 17, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 33,442 | $8.06 | $269.5K | 0 |
| May 12, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 21,167 | $8.11 | $171.7K | 0 |
| May 6, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 27,311 | $8.60 | $234.8K | 0 |
| Feb 11, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 240,000 | $5.00 | $1.20M | 2,884,120 |
| Dec 26, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 4,500 | $4.65 | $20.9K | 3,270,920 |
| Dec 16, 2024↗ | Mosseri Marlio Charles | 10% Owner | Buy | 17,000 | $4.70 | $79.9K | 2,612,000 |
| Nov 20, 2024↗ | Poradosu Enrique | Chief Science & Business Off | Buy | 2,000 | $4.99 | $10.0K | 1,506,320 |
| Nov 18, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 20,000 | $4.92 | $98.4K | 3,266,420 |
| Nov 8, 2024↗ | Carson Michael J. | Vice President, Finance | Sell | 2,755 | $8.16 | $22.5K | 87,918 |
| May 15, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 1,940 | $6.74 | $13.1K | 3,246,420 |
| May 13, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 2,000 | $6.40 | $12.8K | 3,244,480 |
| May 13, 2024↗ | Poradosu Enrique | Chief Science & Business Off | Buy | 500 | $6.29 | $3.1K | 1,504,320 |
| May 13, 2024↗ | Shemesh Shay | Chief Dev. & Ops. Officer | Buy | 1,113 | $6.32 | $7.0K | 1,493,070 |
| Mar 19, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $10.29 | $51.5K | 3,242,480 |
| Oct 12, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 640 | $11.08 | $7.1K | 3,237,480 |
| Oct 10, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 1,080 | $11.21 | $12.1K | 3,236,840 |
| Oct 6, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 3,220 | $11.01 | $35.5K | 3,235,760 |
| Aug 16, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 350 | $14.61 | $5.1K | 3,232,540 |
| Aug 11, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 300 | $14.73 | $4.4K | 3,232,190 |
| Aug 1, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 860 | $13.88 | $11.9K | 2,595,000 |
| Jul 31, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 2,584 | $13.91 | $35.9K | 2,594,140 |
| Jul 28, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 1,556 | $13.98 | $21.8K | 2,591,560 |
| Jul 27, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $13.97 | $139.7K | 2,590,000 |
| Jul 24, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 335 | $14.92 | $5.0K | 3,231,890 |
| Jul 24, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 8,238 | $14.47 | $119.2K | 2,580,000 |
| Jul 20, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 200 | $14.33 | $2.9K | 3,231,560 |
| Jul 20, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 8,000 | $14.84 | $118.7K | 2,571,760 |
| Jul 19, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 9,149 | $14.84 | $135.8K | 2,563,760 |
| Jul 18, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 260 | $15.52 | $4.0K | 3,231,360 |
| Jul 13, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 3,285 | $15.09 | $49.6K | 2,554,610 |
| Jul 12, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $15.36 | $153.6K | 2,551,330 |
| Jul 10, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 8,948 | $15.19 | $135.9K | 2,541,330 |
| Jul 7, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 320 | $14.88 | $4.8K | 3,231,100 |
| Jul 7, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 3,179 | $15.01 | $47.7K | 2,532,380 |
| Jul 6, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 1,176 | $15.52 | $18.3K | 2,529,200 |
| Jun 27, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 750 | $16.50 | $12.4K | 3,230,780 |
| Jun 27, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 16,760 | $16.46 | $275.9K | 2,528,020 |
| Jun 26, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 73,175 | $17.43 | $1.28M | 2,511,260 |
| Jun 23, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 13,090 | $17.72 | $232.0K | 2,438,090 |
| Jun 22, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 500 | $17.88 | $8.9K | 3,230,030 |
| Jun 20, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 12,700 | $17.75 | $225.4K | 2,425,000 |
| Jun 16, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 32,124 | $17.71 | $568.8K | 2,412,300 |
| Jun 8, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 350 | $17.45 | $6.1K | 3,229,530 |
| Jun 1, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 330 | $17.28 | $5.7K | 3,229,180 |
| May 26, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 200 | $17.49 | $3.5K | 3,228,850 |
Showing 1–50 of 92
1 / 2
NVCT Insider Buying Activity
The following table shows recent insider purchases of Nuvectis Pharma, Inc. (NVCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 5, 2025↗ | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $5.72 | $28.6K | 0 |
| Nov 5, 2025↗ | Kaplan Matthew L. | Director | Buy | 11,000 | $5.84 | $64.2K | 0 |
| Nov 5, 2025↗ | Sanchez Juan | Director | Buy | 13,000 | $5.79 | $75.3K | 0 |
| Oct 23, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 154,770 | $6.18 | $957.1K | 0 |
| Jun 20, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 5,603 | $7.99 | $44.8K | 0 |
| Jun 17, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 33,442 | $8.06 | $269.5K | 0 |
| May 12, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 21,167 | $8.11 | $171.7K | 0 |
| May 6, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 27,311 | $8.60 | $234.8K | 0 |
| Feb 11, 2025↗ | Mosseri Marlio Charles | 10% Owner | Buy | 240,000 | $5.00 | $1.20M | 2,884,120 |
| Dec 26, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 4,500 | $4.65 | $20.9K | 3,270,920 |
| Dec 16, 2024↗ | Mosseri Marlio Charles | 10% Owner | Buy | 17,000 | $4.70 | $79.9K | 2,612,000 |
| Nov 20, 2024↗ | Poradosu Enrique | Chief Science & Business Off | Buy | 2,000 | $4.99 | $10.0K | 1,506,320 |
| Nov 18, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 20,000 | $4.92 | $98.4K | 3,266,420 |
| May 15, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 1,940 | $6.74 | $13.1K | 3,246,420 |
| May 13, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 2,000 | $6.40 | $12.8K | 3,244,480 |
| May 13, 2024↗ | Poradosu Enrique | Chief Science & Business Off | Buy | 500 | $6.29 | $3.1K | 1,504,320 |
| May 13, 2024↗ | Shemesh Shay | Chief Dev. & Ops. Officer | Buy | 1,113 | $6.32 | $7.0K | 1,493,070 |
| Mar 19, 2024↗ | BENTSUR RON | Chairman & CEO | Buy | 5,000 | $10.29 | $51.5K | 3,242,480 |
| Oct 12, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 640 | $11.08 | $7.1K | 3,237,480 |
| Oct 10, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 1,080 | $11.21 | $12.1K | 3,236,840 |
| Oct 6, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 3,220 | $11.01 | $35.5K | 3,235,760 |
| Aug 16, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 350 | $14.61 | $5.1K | 3,232,540 |
| Aug 11, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 300 | $14.73 | $4.4K | 3,232,190 |
| Aug 1, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 860 | $13.88 | $11.9K | 2,595,000 |
| Jul 31, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 2,584 | $13.91 | $35.9K | 2,594,140 |
| Jul 28, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 1,556 | $13.98 | $21.8K | 2,591,560 |
| Jul 27, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $13.97 | $139.7K | 2,590,000 |
| Jul 24, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 335 | $14.92 | $5.0K | 3,231,890 |
| Jul 24, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 8,238 | $14.47 | $119.2K | 2,580,000 |
| Jul 20, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 200 | $14.33 | $2.9K | 3,231,560 |
| Jul 20, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 8,000 | $14.84 | $118.7K | 2,571,760 |
| Jul 19, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 9,149 | $14.84 | $135.8K | 2,563,760 |
| Jul 18, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 260 | $15.52 | $4.0K | 3,231,360 |
| Jul 13, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 3,285 | $15.09 | $49.6K | 2,554,610 |
| Jul 12, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 10,000 | $15.36 | $153.6K | 2,551,330 |
| Jul 10, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 8,948 | $15.19 | $135.9K | 2,541,330 |
| Jul 7, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 320 | $14.88 | $4.8K | 3,231,100 |
| Jul 7, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 3,179 | $15.01 | $47.7K | 2,532,380 |
| Jul 6, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 1,176 | $15.52 | $18.3K | 2,529,200 |
| Jun 27, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 750 | $16.50 | $12.4K | 3,230,780 |
| Jun 27, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 16,760 | $16.46 | $275.9K | 2,528,020 |
| Jun 26, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 73,175 | $17.43 | $1.28M | 2,511,260 |
| Jun 23, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 13,090 | $17.72 | $232.0K | 2,438,090 |
| Jun 22, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 500 | $17.88 | $8.9K | 3,230,030 |
| Jun 20, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 12,700 | $17.75 | $225.4K | 2,425,000 |
| Jun 16, 2023↗ | Mosseri Marlio Charles | 10% Owner | Buy | 32,124 | $17.71 | $568.8K | 2,412,300 |
| Jun 8, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 350 | $17.45 | $6.1K | 3,229,530 |
| Jun 1, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 330 | $17.28 | $5.7K | 3,229,180 |
| May 26, 2023↗ | BENTSUR RON | Chairman & CEO | Buy | 200 | $17.49 | $3.5K | 3,228,850 |
NVCT Insider Selling Activity
The following table shows recent insider sales of Nuvectis Pharma, Inc. (NVCT) stock reported via SEC Form 4 filings.
| Date | Insider | Role | Type | Shares | Avg Price | Value | Shares After |
|---|---|---|---|---|---|---|---|
| Nov 8, 2024↗ | Carson Michael J. | Vice President, Finance | Sell | 2,755 | $8.16 | $22.5K | 87,918 |
NVCT Insiders
Similar Stocks to NVCT
VRTX
Vertex Pharmaceuticals Incorporated
$452.29-2.20%
$121.44B
REGN
Regeneron Pharmaceuticals, Inc.
$745.34-1.66%
$77.57B
ALNY
Alnylam Pharmaceuticals, Inc.
$317.24-0.96%
$42.07B
INSM
Insmed Incorporated
$143.85-0.06%
$30.07B
UTHR
United Therapeutics Corporation
$531.23-1.63%
$23.50B
MRNA
Moderna, Inc.
$52.27-3.15%
$20.76B
ROIV
Roivant Sciences Ltd.
$27.86-1.55%
$20.08B
RPRX
Royalty Pharma plc
$45.94-0.36%
$19.56B